Delivery Order SPE2DX22D0010-SPE2D826FAZ46

The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $44,402.40 to AmerisourceBergen Drug Corp on November 11, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor and critical healthcare solutions provider to federal medical procurement programs.

AmerisourceBergen Drug Corp is a leading supplier of pharmaceutical products and medical supplies to Defense Department and veteran healthcare systems, with a demonstrated portfolio encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's $1 billion prime IDC with DLA Troop Support Medical serves as a comprehensive global pharmaceutical support vehicle enabling supply to military healthcare programs worldwide, with the DLA currently planning to establish new Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions. This delivery order reflects AmerisourceBergen's continued capability to meet federal procurement requirements through competitive award processes and supports the broader Defense Logistics Agency mission of sustaining medical supply chains for Department of Defense and related federal healthcare entities.